114 related articles for article (PubMed ID: 28197007)
1. Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review.
Pakhre A; Krishnan A; Pattanayak RD; Khandelwal SK
Indian J Psychiatry; 2016; 58(4):462-466. PubMed ID: 28197007
[TBL] [Abstract][Full Text] [Related]
2. Case report: clozapine given in the context of chemotherapy for lung cancer.
Goulet K; Grignon S
Psychooncology; 2008 May; 17(5):512-6. PubMed ID: 17847125
[TBL] [Abstract][Full Text] [Related]
3. The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder.
Kant R; Chalansani R; Chengappa KN; Dieringer MF
J Child Adolesc Psychopharmacol; 2004; 14(1):57-63. PubMed ID: 15142392
[TBL] [Abstract][Full Text] [Related]
4. Successful clozapine continuation during chemotherapy for the treatment of malignancy: a case report.
Overbeeke MR; Beex-Oosterhuis MM; Graveland E; Hoed-van Wijk JN; Van Gool AR
Int J Clin Pharm; 2016 Apr; 38(2):199-202. PubMed ID: 26951123
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
[TBL] [Abstract][Full Text] [Related]
6. Clozapine in treatment-refractory mood disorders.
Kimmel SE; Calabrese JR; Woyshville MJ; Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():91-3. PubMed ID: 7961583
[TBL] [Abstract][Full Text] [Related]
7. Clozapine in the management of bipolar and schizoaffective manic episodes resistant to standard treatment.
Mahmood T; Devlin M; Silverstone T
Aust N Z J Psychiatry; 1997 Jun; 31(3):424-6. PubMed ID: 9226089
[TBL] [Abstract][Full Text] [Related]
8. Pericarditis and polyserositis as a side effect of clozapine in an adolescent girl.
Branik E; Nitschke M
J Child Adolesc Psychopharmacol; 2004; 14(2):311-4. PubMed ID: 15319027
[TBL] [Abstract][Full Text] [Related]
9. The long-term effectiveness of clozapine and lamotrigine in a patient with treatment-resistant rapid-cycling bipolar disorder.
Bastiampillai TJ; Reid CE; Dhillon R
J Psychopharmacol; 2010 Dec; 24(12):1834-6. PubMed ID: 20142304
[TBL] [Abstract][Full Text] [Related]
10. Low doses of clozapine may stabilize treatment-resistant bipolar patients.
Fehr BS; Ozcan ME; Suppes T
Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):10-4. PubMed ID: 15538596
[TBL] [Abstract][Full Text] [Related]
11. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
Kolli V; Denton K; Borra D; Pulluri M; Sharma A
Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
[TBL] [Abstract][Full Text] [Related]
12. [A review on augmentation of clozapine treatment].
Anil AE; Turgut IT; Rezaki M; Göğüş A
Turk Psikiyatri Derg; 2002; 13(1):65-77. PubMed ID: 12792834
[TBL] [Abstract][Full Text] [Related]
13. Clozapine for treatment-refractory mania.
Calabrese JR; Kimmel SE; Woyshville MJ; Rapport DJ; Faust CJ; Thompson PA; Meltzer HY
Am J Psychiatry; 1996 Jun; 153(6):759-64. PubMed ID: 8633686
[TBL] [Abstract][Full Text] [Related]
14. Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series.
Hummel B; Dittmann S; Forsthoff A; Matzner N; Amann B; Grunze H
Neuropsychobiology; 2002; 45 Suppl 1():37-42. PubMed ID: 11893876
[TBL] [Abstract][Full Text] [Related]
15. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
[TBL] [Abstract][Full Text] [Related]
16. [Clozapine in the treatment of refractory rapid cycling bipolar disorder].
Lançon C; Llorca PM
Encephale; 1996; 22(6):468-9. PubMed ID: 10901840
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?].
van Gool AR; van der Velden MT; Oosten AW; van Meerten E; Verhoeven WM; Loonen AJ
Tijdschr Psychiatr; 2008; 50(10):673-8. PubMed ID: 18951346
[TBL] [Abstract][Full Text] [Related]
18. Clozapine monotherapy for 66 months in treatment resistant bipolar disorder: a case report.
Gupta M
J Clin Psychopharmacol; 2009 Oct; 29(5):501-3. PubMed ID: 19745655
[No Abstract] [Full Text] [Related]
19. Evidence-based options for treatment-resistant adult bipolar disorder patients.
Poon SH; Sim K; Sum MY; Kuswanto CN; Baldessarini RJ
Bipolar Disord; 2012 Sep; 14(6):573-84. PubMed ID: 22938165
[TBL] [Abstract][Full Text] [Related]
20. Reintroduction of clozapine after perforation of the large intestine--a case report and review of the literature.
Ikai S; Suzuki T; Uchida H; Mimura M; Fujii Y
Ann Pharmacother; 2013; 47(7-8):e31. PubMed ID: 23757383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
